Moreover, in JAK2-mutated MPNs two routes of leukemic transformation have been demonstrated by analyzing 16 patients with a JAK2-mutant or JAK2 wild-type acute myeloid leukemia after a JAK2-mutated MPN [24]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.